Pleiotropic resistance and drug development.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line; D004317:Doxorubicin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D006801:Humans; D007941:Leukemia P388 / Q000188:drug therapy; D051379:Mice; D008954:Models, Biological
D000970:Antineoplastic Agents; D004317:Doxorubicin